WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

A REVIEW ARTICLE ON ANTI-OBESITY DRUGS OF HAREETAKYADI VARGA IN BHAVPRAKASH NIGHANTU

Dr. Shivangi Mittal* and Dr. Shiromani Mishra

.

Abstract

Growing prevalence of obesity worldwide is an increasing concern. In Ayurveda obesity is regarded as Medoroga. Retention and deposition of serum lipids resulting in decreased flow of blood in coronary arteries being the underlying cause. In Ayurveda herbal drugs are being used to lower the levels of serum cholesterol. This review article is aimed at gathering data on herbal remedies that have been evaluated for their efficacy as an ANTI-OBESITY remedy in Bhavprakash Nighantu. Bhavprakash Nighantu is one of the oldest texts of Ayurvedic literature. The author of this text is Acharya Bhav Prakash Mishra. Bhavprakash Nighantu is divided into 23 Vargas. Each Vargas named on their main drug. First varga is Hareetkyadi varga. It contains 98 drugs. Few of them are described in this article. The drugs which possesses Katu, Tikta Rasa, Ushna veerya, Laghu and Rukshna Guna and Vatakaphara actions expected to increase the power of Rasa and Medadhatvagni, decrease in Kapha and Vata Dosha thus decrease formation of Meda Dhatu and its deposition.

Keywords: Obesity, herbal drugs, Bhavprakash Nighantu, lifestyle disorder.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More